Patent · US Expired

Gene involved in CADASIL, method of diagnosis and therapeutic application

US7138234B2 · kind B2 · utility

0Cited by

0References

22Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR

Inventors

Elisabeth Tournier-Lasserve · Paris, FR
Anne Joutel · Paris, FR
Marie-Germaine Bousser · Paris, FR
Jean-Francois Bach · Paris, FR

Key dates

Filing date	Feb 3, 2003
Grant date	Nov 21, 2006
Priority date	—
Expiry date	Oct 19, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns the Notch3 gene and the corresponding protein, which are involved in CADASIL. The invention concerns, in particular, methods for demonstrating mutations in this gene, which are linked to the risk of developing CADASIL and related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.